ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,662Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 973

$1.77M Total Retail Price of All Prescriptions

Rank: 3 out of 973

512 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 512 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 512 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 15,356 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 1,038 534 1 3
LEVOTHYROXINE SODIUM 762 581 2 2
SIMVASTATIN 759 402 3 1
FUROSEMIDE 702 546 4 6
HYDROCODONE-ACETAMINOPHEN 549 540 S3 5 4
AMLODIPINE BESYLATE 542 348 6 7
NAMENDA 455 450 7 31
DONEPEZIL HCL 436 436 8 26
SERTRALINE HCL 407 288 9 21
CITALOPRAM HBR 407 237 9 14
METFORMIN HCL 404 144 11 8
MIRTAZAPINE 404 358 11 43
WARFARIN SODIUM 402 320 13 10
BENZTROPINE MESYLATE 390 25 R 14 124
POTASSIUM CHLORIDE 390 335 14 9
GABAPENTIN 381 281 16 12
OMEPRAZOLE 374 186 17 5
TRAZODONE HCL 363 187 18 48
ATORVASTATIN CALCIUM 356 96 19 15
DIVALPROEX SODIUM ER 335 70 20 148
RANITIDINE HCL 327 89 21 45
METOPROLOL TARTRATE 318 226 22 13
HYDROCHLOROTHIAZIDE 312 134 23 11
CLOZAPINE 299 0 24 144
ESCITALOPRAM OXALATE 287 219 25 68
DIVALPROEX SODIUM 254 182 26 86
FLUTICASONE PROPIONATE 251 90 27 35
INSULIN SYRINGE 241 147 28 153
QUETIAPINE FUMARATE 241 191 28 70
LOVASTATIN 241 175 28 38
CARVEDILOL 240 151 31 27
POLYETHYLENE GLYCOL 3350 238 137 32 36
RISPERIDONE 232 53 33 65
OLANZAPINE 229 127 34 122
ABILIFY 209 29 35 146
ADVAIR DISKUS 204 121 36 60
LANTUS 200 111 37 39
TRAMADOL HCL 194 101 38 18
EXELON 191 185 39 117
TAMSULOSIN HCL 189 141 40 28
CYMBALTA 177 113 41 40
ALENDRONATE SODIUM 175 151 42 24
IBUPROFEN 168 30 43 102
BUSPIRONE HCL 161 125 44 98
TRICOR 154 14 45 143
CLONIDINE HCL 149 41 46 67
KLOR-CON M20 142 58 47 64
FAZACLO 137 21 48 283
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 91 49 25
PANTOPRAZOLE SODIUM 134 98 50 37
HALOPERIDOL 130 14 51 176
LANTUS SOLOSTAR 130 37 51 99
FAMOTIDINE 129 53 53 61
GLIPIZIDE 128 77 54 69
CARBIDOPA-LEVODOPA 128 128 54 71
METOPROLOL SUCCINATE 124 80 56 17
PAROXETINE HCL 122 20 57 66
LEVETIRACETAM 121 57 58 162
FLUOXETINE HCL 121 83 58 56
HUMALOG 119 73 60 127
ATENOLOL 113 53 61 16
OXYBUTYNIN CHLORIDE 112 45 62 92
PREDNISONE 109 93 63 33
PROAIR HFA 107 25 64 54
CEPHALEXIN 105 71 65 75
NOVOLOG 104 73 66 82
SEROQUEL 104 75 66 150
AMITIZA 103 59 68 307
VENLAFAXINE HCL ER 101 64 69 95
CLOTRIMAZOLE-BETAMETHASONE 100 33 70 164
PHENYTOIN SODIUM EXTENDED 97 50 71 141
SULFAMETHOXAZOLE-TRIMETHOPRIM 96 70 72 76
FENTANYL 91 90 S2 73 53
LIPITOR 90 16 74 139
ZYPREXA 87 28 75 267
VENLAFAXINE HCL 85 66 76 192
NEXIUM 85 32 76 30
CELEBREX 85 51 76 91
LIDODERM 83 62 79 147
LAMOTRIGINE 82 38 80 175
SPIRONOLACTONE 81 44 81 49
RISPERDAL CONSTA 77 18 82 187
NOVOLIN R 77 13 82 286
ALLOPURINOL 75 53 84 29
CHLORHEXIDINE GLUCONATE 75 0 84 255
CARBAMAZEPINE 74 0 86 165
TRIAMCINOLONE ACETONIDE 74 28 86 120
ZOLPIDEM TARTRATE 73 41 88 20
NOVOLOG FLEXPEN 72 27 89 168
LEXAPRO 72 44 89 208
COMBIVENT 71 16 91 186
PRENATAL PLUS 71 34 91 272
PEN NEEDLE 71 13 91 171
IPRATROPIUM-ALBUTEROL 69 65 94 115
OXYBUTYNIN CHLORIDE ER 69 30 94 125
LEVOFLOXACIN 68 57 96 84
TRIHEXYPHENIDYL HCL 68 12 R 96 276
LATANOPROST 67 39 98 229
DOXYCYCLINE HYCLATE 67 49 98 96
KLOR-CON M10 66 46 100 130
NIASPAN 66 17 100 132
GEMFIBROZIL 65 0 102 83
CLOPIDOGREL 65 55 102 44
BUPROPION HCL SR 64 36 104 197
HYDROXYZINE PAMOATE 63 0 R 105 333
DILTIAZEM 24HR CD 62 40 106 104
DETROL LA 62 24 106 136
TRAVATAN Z 60 31 108 226
OXYCODONE-ACETAMINOPHEN 60 47 S2 108 89
INVEGA 59 0 110 288
CYCLOBENZAPRINE HCL 59 28 R 110 42
MUPIROCIN 59 21 110 151
HYDROCORTISONE 58 45 113 221
LOSARTAN POTASSIUM 57 38 114 19
LOXAPINE 57 15 114 266
GLIPIZIDE XL 57 32 114 239
NYSTATIN 57 48 114 149
RAMIPRIL 54 42 118 114
DIOVAN 53 41 119 63
DESMOPRESSIN ACETATE 53 0 119 367
RIVASTIGMINE 52 47 121 259
LACTULOSE 52 14 121 199
ISOSORBIDE MONONITRATE ER 51 51 123 85
KETOCONAZOLE 51 41 123 219
DIGOXIN 50 45 125 32
ROPINIROLE HCL 50 41 125 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.